Written by Klarity Editorial Team
Published: Sep 1, 2026

Last updated: September 1, 2026
If you have Humana in Texas and you are asking about weight loss treatment, start with the Medicare GLP-1 Bridge. Starting July 1, 2026, CMS describes a demonstration that may give eligible Medicare Part D beneficiaries $50-per-month access to certain GLP-1 medicines, including Wegovy, Zepbound (KwikPen), and Foundayo, through December 31, 2027. That program sits with CMS, not Humana Pharmacy Solutions (HPS) Part D formulary design. Coverage still varies by eligibility, product, and medical necessity. Verify benefits before you book.
See if you may qualify for online weight loss care · Browse conditions
Klarity Health connects patients with 2,000+ licensed providers for evaluation and, when appropriate, medication management via telehealth. This article is educational. It is not a guarantee of coverage, a diagnosis, or a substitute for your Evidence of Coverage.
Humana may cover medically necessary evaluation and some obesity medicines when your MA plan and pharmacy benefit allow it. For many members in 2026, the first question is whether you qualify for the Medicare GLP-1 Bridge. CMS and Medicare.gov describe $50 monthly beneficiary cost for listed products when you meet program rules. That is a CMS demonstration, not a promise that every Humana Texas card fills Wegovy at $50 at every pharmacy.
The CDC NCHS Data Brief 508 reports U.S. adult obesity prevalence of 40.3% during August 2021–August 2023. Demand is high. Plan documents still control what you pay.
Related Texas Humana and commercial guides: Humana TX ADHD, Humana TX anxiety, Humana TX depression, Cigna TX weight loss.
CMS describes the Bridge as access for certain Part D beneficiaries from July 1, 2026 through December 31, 2027. Medicare.gov lists Foundayo (tablet), Wegovy (injection or tablet), and Zepbound (KwikPen only) among the products in the program. HPS still manages many MA pharmacy claims. A drug can appear in the Bridge while remaining non-preferred, PA-required, or absent on a given HPS list. Ask both questions: Bridge eligibility, and your plan’s ordinary formulary.
See CMS’s May 2026 announcement and the Medicare weight-loss drugs page.
Federal MA regulation sits in 42 CFR Part 422. Texas Insurance Code Chapter 1355 and federal MHPAEA apply to many commercial fully insured plans. They do not convert a Humana MA contract into a Texas commercial obesity mandate. Anti-obesity drugs are often excluded or tightly managed even when mental health parity applies to other benefits.
If you hold employer coverage through another carrier, read that carrier’s Texas guide. Do not assume Humana MA rules apply to a Cigna, Aetna, Anthem, or UnitedHealthcare commercial ID card.
Humana Pharmacy Solutions manages Part D and many MA pharmacy benefits. Obesity medicines often need BMI documentation, comorbidity notes, and step therapy. Cigna PA Policy IP0477 (effective May 15, 2026) is a stimulant policy at Express Scripts. Do not treat IP0477 as Humana GLP-1 PA.
Phentermine and Qsymia are Schedule IV. GLP-1s, naltrexone-bupropion (Contrave), and orlistat are typically unscheduled. That split matters for telehealth prescribing workflow.
Texas Insurance Code Chapter 1455 addresses telehealth for many state-regulated plans. Medicare telehealth payment and originating-site rules are federal. A Texas license still matters for the treating clinician. HHS and DEA controlled-substance telemedicine flexibilities currently extend through December 31, 2026. Confirm current federal status before you assume a phentermine or Qsymia refill via video. Typical GLP-1 prescriptions are not controlled substances.
Check if online weight loss care may fit your plan
Evaluation, nutrition counseling, follow-up visits, and medication management are the usual building blocks. Clinicians may discuss GLP-1s, Contrave, orlistat, or phentermine when medically appropriate. Coverage of each visit type and each NDC still depends on your MA Evidence of Coverage, HPS list, and any Bridge eligibility.
Klarity is not an in-network guarantee with Humana. Ask whether your visit is billed as telehealth professional services and whether pharmacy claims run through HPS or the Bridge channel.
For many Texas commercial complaints, TDI’s Help Line is 800-252-3439 (8 a.m. to 5 p.m. Central, Monday–Friday). Humana MA organization determinations typically follow Medicare: plan reconsideration, then Independent Review Entity. Maximus Federal Services IRE is often reached at 1-855-887-6668. TDI does not replace CMS jurisdiction over MAPD.
Zepbound formulary changes at CVS/Caremark (removed July 1, 2025; reinstated October 1, 2026) describe Aetna/commercial obesity pharmacy, not Humana HPS. Cigna/ESI did not follow that Caremark removal. Those commercial stories do not rewrite Humana MA in Texas.
STAR, CHIP, and Medicaid are separate. Dual-eligible members should confirm which payer is primary. This page does not claim Humana is a Texas Medicaid MCO for weight loss care.
Insurance coverage varies by plan, formulary, prior authorization, and medical necessity. Verify benefits with Humana and, when relevant, CMS before you book. This content is not medical advice. If you are in crisis, call or text 988.
See if you may qualify for online weight loss care
Find the right provider for your needs — select your state to find expert care near you.